GB2131293A - Composition containing dextran for use in medical treatment - Google Patents
Composition containing dextran for use in medical treatment Download PDFInfo
- Publication number
- GB2131293A GB2131293A GB08234504A GB8234504A GB2131293A GB 2131293 A GB2131293 A GB 2131293A GB 08234504 A GB08234504 A GB 08234504A GB 8234504 A GB8234504 A GB 8234504A GB 2131293 A GB2131293 A GB 2131293A
- Authority
- GB
- United Kingdom
- Prior art keywords
- composition
- collagen
- dextran
- weight
- gelatinous material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
- C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
- C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dental Preparations (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
A pasty composition comprising collagen or other collagen-type gelatinous material, dextran and an aqueous saline solution or the like is useful as a dressing in the treatment of dry sockets following tooth extraction or for other medical purposes.
Description
SPECIFICATION
Composition for use in medical treatment
The present invention relates to a composition for use in medical treatment, particularly but not exclusively in dentistry as a dressing for treatment of dry sockets following tooth extraction.
In dentistry a not uncommon sequel to tooth extraction is the development of a dry socket. One to three days post-extraction there is partial or complete disintegration of the blood clot. Any remaining clot is heavily contaminated. Large areas of the lamina dura are necrotic and osteocyte lacunae are empty. The inflammatory process spreads to the surrounding marrow spaces and often to the periosteum. A heavy subepithelial inflammation is seen in the gingiva. Necrotic tissue is found in the marrow spaces closest to the alveolus. In the marrow space thrombosis, the presence of polymorphonuclear leukocytes and mononuclear cells present a picture of a localised acute or subacute osteomyelitis. Extensive osteoclastic activity is seen and the repair process is delayed.Granulation tissue starts to grow into the alveolus from the perforations in the lamina dura and the healing process progresses from the base of the socket.
In man, fibrinolytic alveolitis presents two problems: namely persistent pain and delayed healing.
At present many non-physiological dressings acting as a mechanical barrier and antiseptic are used with or without a curettage of the socket. They include obtundant materials such as eugenol or oil of cloves mixed into a paste with zinc oxide, or Whitehead's varnish (benzoin, storax, balsam of Tolu, iodoform, solvent ether) placed on ribbon gauze. More recently the dextran polymer Debrisan has been advocated, but its use in the mouth has presented isolation problems and patients are requested to return daily for a change of packing.
The present invention seeks to provide an improved dressing for this purpose.
According to the invention there is provided a composition useful as a dressing in medical treatment, comprising collagen-type gelatinous material, dextran and an aqueous solution of a physiologically harmless electrolyte.
Preferably the gelatinous material comprises collagen. The collagen may be of heterogeneous origin and may be soluble or insoluble or may be a mixture of soluble and insoluble material in any proportion. The use of a mixture of soluble and insoluble collagen in proportions by weight from 2:1 to 1 :2, especially about equal proportions, is particularly desirable. However, other gelatinous materials having a structure similar to that of collagen, namely polypeptide strands of molecularweight in the region of 105, may also be used.
The dextran to be used is a glucose polymer of chain-like structure and is obtainable in a variety of molecular weights. Preferably the material used has a molecular weight in the range 60,000 - 90,000, for example Dextran 70 with a molecular weight of 70,000.
The aqueous solution is preferably a saline solution for antiseptic purposes, but other electrolyte solutions which do not harm the patient may be used.
The composition may, if desired, contain other ingredients, for various purposes. For example, glycerol may be present to act as an emulsifier or lubricant.
For best results the composition is desirably applied in the form of a paste with sufficient of the aqueous solution to achieve the desired pasty consistency. Suitably about 45 - 50% by weight of the aqueous solution is used. The major proportion of the solid material should be the collagen-type, for example 75 - 90% by weight of the solid material, with the dextran suitably constituting 10 to 25% by weight of the solid material.
Particularly preferred compositions have the following constitution by weight:
insoluble collagen 20-25% e.g. 22% soluble collagen 20-25% e.g. 22%
dextran 5-10% e.g. 8%
normal saline solution 45-50% e.g. 48% It will be appreciated that, although the composition used as a dressing will contain the aqueous electrolyte solution, the aqueous solution can be mixed with the other ingredients just before use, so that the invention also includes a composition comprising simply the collagen-type material and the dextran prior to addition of water.
In use to treat the dry socket condition in dentistry the composition is applied, suitably as a stiff paste, direct to the area of denuded bone. When used for this purpose it has the following advantages:
1. It relieves pain.
2. It is non-irritant to surrounding tissues.
3. It is incorporated or absorbed.
4. It is antiseptic.
5. It is a good bone sealant.
6. It is stable in oral fluids.
7. It does not undergo volume change when exposed to blood/saliva.
8. It is non-antigenic.
9. It is easy to apply.
10. Its use necessitates only a one visit treatment.
The composition may also be used outside dentistry for other medical purposes. For example, it would be of value in achieving haemostasis in bleeding bone, where it would act as a bone sealant, in orthopaedic, neuro-surgical or other related surgical fields. It would also have uses for patients with bleeding diathesis for local control of bleeding from bone. It would also act as a space filler in bony cavities when cyst-like lesions are removed in the above and similar surgical disciplines.
CLAIMS (Filed on 30.11.83)
1. A composition useful as a dressing in dental or other medical treatment, comprising collagen-type gelatinous material, dextran and an aqueous solution of a physiologically harmless electrolyte.
2. A composition as claimed in claim 1, wherein the ratio by weight of the gelatinous material to the dextran in the composition is from 3:1 to 9:1.
3. A composition as claimed in claim 1 or 2, wherein the composition is in the form of a paste containing 45 to 50% by weight of the aqueous solution.
4. A composition as claimed in any of claims 1 to 3, wherein the gelatinous material is collagen.
5. A composition as claimed in any of claims 1 to 4, wherein the collagen is a mixture of soluble collagen and insoluble collagen in a ratio by weight of from 1:2 to 2:1.
6. A composition as claimed in any of claims 1 to 5, wherein the dextran has a molecular weight of 60,000 to 90,000.
7. A composition as claimed in any of claims 1 to 6, which also contains glycerol as an emulsifier/ lubricant.
8. A composition as claimed in claim 1 and substantially as hereinbefore described.
9. A composition comprising collagen-type gelatinous material and dextran and being capable of forming a composition as claimed in any of claims 1 to 8 on addition of an aqueous solution of a physiologically harmless electrolyte.
**WARNING** end of DESC field may overlap start of CLMS **.
Claims (9)
1. A composition useful as a dressing in dental or other medical treatment, comprising collagen-type gelatinous material, dextran and an aqueous solution of a physiologically harmless electrolyte.
2. A composition as claimed in claim 1, wherein the ratio by weight of the gelatinous material to the dextran in the composition is from 3:1 to 9:1.
3. A composition as claimed in claim 1 or 2, wherein the composition is in the form of a paste containing 45 to 50% by weight of the aqueous solution.
4. A composition as claimed in any of claims 1 to 3, wherein the gelatinous material is collagen.
5. A composition as claimed in any of claims 1 to 4, wherein the collagen is a mixture of soluble collagen and insoluble collagen in a ratio by weight of from 1:2 to 2:1.
6. A composition as claimed in any of claims 1 to 5, wherein the dextran has a molecular weight of 60,000 to 90,000.
7. A composition as claimed in any of claims 1 to 6, which also contains glycerol as an emulsifier/ lubricant.
8. A composition as claimed in claim 1 and substantially as hereinbefore described.
9. A composition comprising collagen-type gelatinous material and dextran and being capable of forming a composition as claimed in any of claims 1 to 8 on addition of an aqueous solution of a physiologically harmless electrolyte.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB08234504A GB2131293B (en) | 1982-12-03 | 1982-12-03 | Composition containing dextran for use in medical treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB08234504A GB2131293B (en) | 1982-12-03 | 1982-12-03 | Composition containing dextran for use in medical treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2131293A true GB2131293A (en) | 1984-06-20 |
GB2131293B GB2131293B (en) | 1986-03-05 |
Family
ID=10534718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08234504A Expired GB2131293B (en) | 1982-12-03 | 1982-12-03 | Composition containing dextran for use in medical treatment |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2131293B (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0224453A2 (en) * | 1985-11-26 | 1987-06-03 | Pierfrancesco Morganti | Biologically active topical collagen support matrix: cosmetic and pharmaceutical uses and a process for its preparation |
FR2591892A1 (en) * | 1985-12-23 | 1987-06-26 | Pf Medicament | COLLAGEN ASSOCIATION / ACTIVEANTISEPTIC AND / OR ANTI-INFLAMMATORY PRINCIPLE AS COMPOSITION, PROCESS FOR PREPARING THE SAME AND USE THEREOF FOR THE PRODUCTION OF A PHARMACEUTICAL COMPOSITION |
EP0246809A2 (en) * | 1986-05-19 | 1987-11-25 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Sustained-release pharmaceutical compositions |
EP0250571A1 (en) * | 1986-01-06 | 1988-01-07 | Univ Melbourne | Precipitation of collagen in tactoid form. |
EP0572272A1 (en) * | 1992-05-29 | 1993-12-01 | JOHNSON & JOHNSON MEDICAL, INC. | Absorbable bone sealant |
US6280474B1 (en) | 1997-01-09 | 2001-08-28 | Neucoll, Inc. | Devices for tissue repair and methods for preparation and use thereof |
EP1241226A1 (en) * | 2001-03-16 | 2002-09-18 | Swiss Caps Rechte und Lizenzen AG | Use of a polyol as a gelling agent for cold-water soluble gelatin gels. Films, articles and capsules formed therefrom |
-
1982
- 1982-12-03 GB GB08234504A patent/GB2131293B/en not_active Expired
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0224453A3 (en) * | 1985-11-26 | 1988-10-26 | Pierfrancesco Morganti | Biologically active topical collagen support matrix: cosmetic and pharmaceutical uses and a process for its preparation |
EP0224453A2 (en) * | 1985-11-26 | 1987-06-03 | Pierfrancesco Morganti | Biologically active topical collagen support matrix: cosmetic and pharmaceutical uses and a process for its preparation |
FR2591892A1 (en) * | 1985-12-23 | 1987-06-26 | Pf Medicament | COLLAGEN ASSOCIATION / ACTIVEANTISEPTIC AND / OR ANTI-INFLAMMATORY PRINCIPLE AS COMPOSITION, PROCESS FOR PREPARING THE SAME AND USE THEREOF FOR THE PRODUCTION OF A PHARMACEUTICAL COMPOSITION |
EP0233429A1 (en) * | 1985-12-23 | 1987-08-26 | Pierre Fabre Medicament | Pharmaceutical composition containing a mixture of collagen and an antiseptic and/or anti-inflammatory effective substance and process for its manufacture |
US4789662A (en) * | 1985-12-23 | 1988-12-06 | Pierre Fabre Medicament | Method for the treatment of periodontal pockets with a composition comprising collagen and an antiseptic or anti-inflammatory substance |
EP0250571A1 (en) * | 1986-01-06 | 1988-01-07 | Univ Melbourne | Precipitation of collagen in tactoid form. |
EP0250571A4 (en) * | 1986-01-06 | 1988-08-17 | Univ Melbourne | Precipitation of collagen in tactoid form. |
EP0246809A2 (en) * | 1986-05-19 | 1987-11-25 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Sustained-release pharmaceutical compositions |
EP0246809A3 (en) * | 1986-05-19 | 1988-01-13 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem | Sustained-release pharmaceutical compositions |
EP0572272A1 (en) * | 1992-05-29 | 1993-12-01 | JOHNSON & JOHNSON MEDICAL, INC. | Absorbable bone sealant |
AU669519B2 (en) * | 1992-05-29 | 1996-06-13 | Johnson & Johnson Medical, Inc. | Absorbable bone sealant |
US6280474B1 (en) | 1997-01-09 | 2001-08-28 | Neucoll, Inc. | Devices for tissue repair and methods for preparation and use thereof |
EP1241226A1 (en) * | 2001-03-16 | 2002-09-18 | Swiss Caps Rechte und Lizenzen AG | Use of a polyol as a gelling agent for cold-water soluble gelatin gels. Films, articles and capsules formed therefrom |
WO2002074861A1 (en) * | 2001-03-16 | 2002-09-26 | Swiss Caps Rechte Und Lizenzen Ag | Use of polyol as a gel former, composition for the production of films and moulded bodies, method for the production of a gelatine gel which is soluble in cold water and method for producing a capsule. |
Also Published As
Publication number | Publication date |
---|---|
GB2131293B (en) | 1986-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5696101A (en) | Oxidized cellulose and vitamin E blend for topical hemostatic applications | |
EP0390541A2 (en) | Paste-like base and preparation | |
EP1206271A1 (en) | Composition and method for enhancing wound healing | |
JP2007506505A (en) | Bioabsorbable putty-like hemostatic implant | |
US10022411B2 (en) | Hemostatic preparation containing an extract of golden moss | |
AU2010335066A1 (en) | Topical oral gel formulations for dental use | |
EP0472575A1 (en) | Improvements in or relating to pharmaceutical preparations | |
DE202016102375U1 (en) | Dental agent based on hyaluronan and octenidine dihydrochloride | |
JP2023516514A (en) | Medical adhesive, its preparation method, and its use | |
GB2131293A (en) | Composition containing dextran for use in medical treatment | |
CA2765271C (en) | Silver hydrosol, dental application and other uses thereof | |
EP0191086A1 (en) | Bone-replacing material | |
AU612387B2 (en) | Pharmaceutical compositions promoting the wound healing and process for preparing same | |
CH643732A5 (en) | Aid for covering and/or filling bone defects and process for the production thereof | |
WO2020249711A1 (en) | Injectable aqueous implant formulation containing ascorbic acid | |
RU2074702C1 (en) | Material for osseous tissue recovery | |
JPH09169612A (en) | Dental root canal filler composition | |
Mitchell | Treatment of fibrinolytic alveolitis by a collagen paste (formula K): A preliminary report | |
RU2653480C1 (en) | Composition for stimulation of regeneration in defects of bone jaw tissue | |
JPH03261643A (en) | Curable composition | |
Carroll et al. | The histologic effect of topically applied acetylsalicylic acid on bone healing in rats | |
de OLIVEIRA RODRIGUES et al. | “Bone Wax” implantation into Dental Sockets Clinical and Histological Evaluation in Patients | |
RU2242987C1 (en) | Hemostatic preparation | |
RU2088240C1 (en) | Method of preparing the preparation for reparative osteogenesis activation | |
SK15212000A3 (en) | A preparation consisting of calcium hydroxide, a dihydric or polyvalent alcohol, a fatty oil of vegetable or animal origin, and its use for regenerating collagen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19981203 |